Suggestions
Jacques Galipeau
Associate Dean for Therapeutics Development at University of Wisconsin-Madison
Jacques Galipeau is a prominent figure in the field of cell and gene therapy, with extensive experience in academic medicine and biopharmaceutical leadership. Here's an overview of his professional background and current roles:
Current Positions
Associate Dean for Therapeutics Development: Dr. Galipeau currently serves as the Associate Dean for Therapeutics Development at the University of Wisconsin-Madison School of Medicine and Public Health, a position he has held since September 2018.1 In this role, he focuses on:
- Identifying collaborative opportunities
- Assembling cross-disciplinary teams for innovation and discovery in cell technologies and therapeutics
- Establishing partnerships within the Wisconsin biotechnology and life sciences ecosystem
ISCT Leadership: At the International Society for Cell & Gene Therapy (ISCT), Dr. Galipeau has held several leadership positions:
- Immediate Past President & Chair, Strategic Advisory Council (current)
- President (May 2022 - recent past)1
- President-Elect (June 2020 - May 2022)1
Professional Background
Dr. Galipeau's career includes:
- Director of the Program for Advanced Cell Therapy (PACT) at the University of Wisconsin-Madison
- Professor of Hematology and Oncology and Director of the Emory Personalized Immunotherapy Center at Emory University in Atlanta, Georgia3
- Associate Professor of Medicine and Oncology at McGill University (June 2004 - October 2009)1
Expertise and Focus
Dr. Galipeau is known for his work in:
- Cell and gene therapy innovations
- Translational research in cellular therapies
- Academic health center biopharmaceutical development
- Advancing early clinical phase development of cell therapies2
His leadership at ISCT has emphasized:
- Providing a voice for the unique challenges and opportunities in the Cell & Gene Therapy field
- Focusing on education and workforce training
- Supporting the growth and impact of the society journal, Cytotherapy
- Shaping the cell therapy ecosystem to improve human health outcomes1
Dr. Galipeau's work spans academic research, clinical translation, and industry collaboration, making him a key figure in advancing cell and gene therapies from laboratory discoveries to patient treatments.
Highlights
The inimitable Lizette Caballero and Ted Kieffer extract my impressions on ISCT, International Society for Cell & Gene Therapy Vancouver meeting to date. Thank you Lauren Reville for ISCT TV clip!
#celltherapy #cellandgenetherapy #FDA #genetherapy #CAR-T #sicklecelldisease #MHRA
